Evidence map›Paper›PMID 37610104›Full record

ArticleEmerging infectious diseases2023

Genomic Characteristics of Emerging Intraerythrocytic Anaplasma capra and High Prevalence in Goats, China.

Zhe-Tao Lin, Li-Feng Du, Ming-Zhu Zhang, Xiao-Yu Han, Bai-Hui Wang, Jiao Meng, Fu-Xun Yu, Xiao-Quan Zhou, Ning Wang, Cheng Li and 12 more

Open access · diamondAbstract read
In one paragraph

Article in Emerging infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Molecular detection and genetic diversity ofFrontiers in microbiology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Genomic characters ofEmerging microbes & infections · 2024
    Article
  7. Anaplasma capra: a new emerging tick-borne zoonotic pathogen.Veterinary research communications · 2024
    Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 3 institutions in 1 country.

Zhe-Tao Lin
Li-Feng Du
Ming-Zhu Zhang
Xiao-Yu Han
Bai-Hui Wang
Jiao Meng
Fu-Xun Yu
Xiao-Quan Zhou
Ning Wang
Cheng Li
Xiao-Yang Wang
Jing Liu
Wan-Ying Gao
Run-Ze Ye
Luo-Yuan Xia
Yi Sun
Na Jia
Jia-Fu Jiang
Lin Zhao
Xiao-Ming Cui
Lin Zhan
Wu-Chun Cao
Institute of Microbiology · CNGuizhou Provincial People's Hospital · CNShandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anaplasma capra is an emerging tickborne human pathogen initially recognized in China in 2015; it has been reported in ticks and in a wide range of domestic and wild animals worldwide. We describe whole-genome sequences of 2 A. capra strains from metagenomic sequencing of purified erythrocytes from infected goats in China. The genome of A. capra was the smallest among members of the genus Anaplasma. The genomes of the 2 A. capra strains contained comparable G+C content and numbers of pseudogenes with intraerythrocytic Anaplasma species. The 2 A. capra strains had 54 unique genes. The prevalence of A. capra was high among goats in the 2 endemic areas. Phylogenetic analyses revealed that the A. capra strains detected in this study were basically classified into 2 subclusters with those previously detected in Asia. Our findings clarify details of the genomic characteristics of A. capra and shed light on its genetic diversity.

Indexed as

GenomicsGoatsAnaplasmaAnimalsChinaHumansPhylogenyPrevalenceAnaplasma caprabacteriabacterial infectionChinagoatsphylogenetic analysisprevalencetickborne diseasesvector-borne infectionswhole-genome analysiszoonoses

Identifiers

PMID37610104
PMCPMC10461651
OpenAlexW4386084837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.